Home › Trial NCT00074165
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
- Trial IDNCT00074165
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorOHSU Knight Cancer Institute
- Enrollment17
- Start date2003-01
- ConditionsBrain and Central Nervous System Tumors · Drug/Agent Toxicity by Tissue/Organ · Lymphoma · Thrombocytopenia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.